Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) für Age-Related Cognitive Decline

A

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dcognitive\u002Ddecline'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Fazit

A systematic review of 58 studies found each 2,000 mg/day of omega-3 showed significant improvements in attention, perceptual speed, language, and primary memory. Research suggests a non-linear dose-response with optimal effects at moderate doses under 1,700 mg/day.

Key Study Findings

Systematic Review
Impact of Vegan and Vegetarian Diets on Neurological Health: A Critical Review.
Dose: None vs.: None Outcome: Neurological health outcomes Wirkung: None None

Population: None

Review
Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Review
Exploring the Efficacy and Safety of Nutritional Supplements in Alzheimer's Disease.
Dose: Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d vs.: None Outcome: Cognitive decline in AD Wirkung: None None

Population: Alzheimer's disease patients

Review
Advanced nutraceutical approaches to Parkinson's disease: bridging nutrition and neuroprotection.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None vs.: None Outcome: None Wirkung: None None

Population: None

In Vitro
Multiplatform Lipid Analysis of the Brain of Aging Mice by Mass Spectrometry.
Dose: None vs.: None Outcome: Age-dependent brain lipid changes Wirkung: None None

Population: Mice: adult (3-4mo), middle-aged (10mo), old (19-21mo)

Key Statistics

58

Studien

12000

Teilnehmer

Positive

A

Bewertung

Referenced Papers

Molecules (Basel, Switzerland) 2025 10 Zitierungen
Journal of Alzheimer's … 2025 3 Zitierungen
Nutrients 2025 2 Zitierungen
Current opinion in … 2023 58 Zitierungen
Nutrients 2022 76 Zitierungen
International journal of … 2022 23 Zitierungen
Current nutrition reports 2019 310 Zitierungen
Nutricion hospitalaria 2019 40 Zitierungen
American family physician 2018 101 Zitierungen
Nutricion hospitalaria 2018 32 Zitierungen
Advances in nutrition … 2017 215 Zitierungen
Nutricion hospitalaria 2014 17 Zitierungen
Advances in nutrition … 2013 155 Zitierungen
Current treatment options … 2011 6 Zitierungen
Molecular neurobiology 2010 145 Zitierungen
Women's health (London, … 2010 48 Zitierungen
JAMA 2010 3 Zitierungen
The Practitioner 2010
The Cochrane database … 2009 299 Zitierungen
Prostaglandins, leukotrienes, and … 2009 258 Zitierungen
Neuro endocrinology letters 2008
The Cochrane database … 2007 375 Zitierungen
Prostaglandins, leukotrienes, and … 2006 176 Zitierungen
Medecine sciences : … 2005 19 Zitierungen
The Cochrane database … 2003 263 Zitierungen
Journal of Alzheimer's … 2003 161 Zitierungen
Pharmacological research 1999 1060 Zitierungen

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Übliche Dosierungen

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Obergrenze: 3,000 mg/day combined DHA/EPA (FDA GRAS)

In der Forschung untersuchte Dosierungen

Dosierung Dauer Wirkung N
None -- Mixed --
None -- Mixed --
Curcumin 800mg/d, omega-3 2g/d, resveratrol 600mg/d -- Mixed --
None -- Mixed --
None -- Mixed --
None -- Mixed --
Vit D 1 mcg/kg + N-3 PUFA 300 mg/kg EPA+DHA 4 weeks Positive 50
None -- Mixed --

Beste Einnahmezeit: With meals containing fat for better absorption

Safety & Side Effects

Gemeldete Nebenwirkungen

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Bekannte Wechselwirkungen

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Tolerierbare Höchstaufnahmemenge: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.Konsultieren Sie immer Ihren Arzt, bevor Sie ein Nahrungsergänzungsmittel einnehmen.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Age-Related Cognitive Decline?
Based on 58 studies with 12,000 participants, there is strong evidence from multiple clinical trials that Omega-3 Fatty Acids (DHA/EPA) may support Age-Related Cognitive Decline management. Our evidence grade is A (Strong Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Age-Related Cognitive Decline?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Age-Related Cognitive Decline?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 58 peer-reviewed studies with 12,000 total participants. The overall direction of effect is positive.

Related Evidence

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.